EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis

Zhongshan He iD, Yaoyao Luo, Shuping Yang, Haixing Shi, Ya-Chih Huang, Zhuoming Zhou, Shengbin Liu iD, Wanqin Zeng, Wei-Chieh Liu, Yongjiang Li iD, Yuting Chen, Duotian Qin und 4 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.5c18044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Zhongshan He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center…. Hauptthemen laut MEDLINE: RNA, Small Interfering, Atherosclerosis, Interferon Regulatory Factors, Macrophages. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Supported by Health Commission of Sichuan Province Medical Science and Technology Program, the Science and Technology Support Program of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingAtherosclerosisInterferon Regulatory FactorsMacrophagesImmunotherapyAnimalsMiceHomeostasisLiposomesMice, Inbred C57BLHumansMale

Stichwörter der Autor:innen

atherosclerosismacrophage homeostasisnanoimmunotherapysmall interfering RNAtargeted delivery

Substanzen

RNA, Small InterferingInterferon Regulatory FactorsIrf5 protein, mouseLiposomes

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Tianfu Jincheng Laboratory,…
  • Departments of Molecular Physiology and Biological Physics & Biomedical Engineering, Cardiovascular Research Center, Virginia University, Charlottesville, Virginia 22903, United States.
  • Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.
  • Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

ORCID-Profile: Zhongshan He, Shengbin Liu, Yongjiang Li, Wei Chen, Xiangrong Song

Förderung

  • Supported by Health Commission of Sichuan Province Medical Science and Technology Program
  • the Science and Technology Support Program of Sichuan Province

Zitieren

APA

He, Z., Luo, Y., Yang, S., Shi, H., Huang, Y. C., Zhou, Z., Liu, S., Zeng, W., Liu, W. C., Li, Y., Chen, Y., Qin, D., Duan, X., He, X., Chen, W., & Song, X. (2026). Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis. ACS Nano. https://doi.org/10.1021/acsnano.5c18044

Vancouver

He Z, Luo Y, Yang S, Shi H, Huang YC, Zhou Z, et al. Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis. ACS Nano. 2026. doi:10.1021/acsnano.5c18044

BibTeX
@article{He2026,
  author = {He, Zhongshan and Luo, Yaoyao and Yang, Shuping and Shi, Haixing and Huang, Ya-Chih and Zhou, Zhuoming and Liu, Shengbin and Zeng, Wanqin and Liu, Wei-Chieh and Li, Yongjiang and Chen, Yuting and Qin, Duotian and Duan, Xing and He, Xi and Chen, Wei and Song, Xiangrong},
  title = {Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c18044}
}
Kostenlos starten →